Amicus Therapeutics, Inc. (FOLD)
14.37
0.00 (0.00%)
USD |
NASDAQ |
Mar 02, 16:00
Amicus Therapeutics Total Liabilities (Quarterly) : 675.63M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 1.507B |
| CorMedix, Inc. | 376.73M |
| Krystal Biotech, Inc. | 114.23M |
| MannKind Corp. | 843.20M |
| Keros Therapeutics, Inc. | 39.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 949.87M |
| Shareholders Equity (Quarterly) | 274.24M |
| Debt to Equity Ratio | 1.613 |
| Current Ratio | 2.843 |
| Net Debt Paydown Yield | 0.01% |